Search hospitals > Colorado > Fort Collins
Cancer Care and Hematology-Fort Collins
Claim this profileFort Collins, Colorado 80528
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Recurrence
Conducts research for Breast Cancer
63 reported clinical trials
27 medical researchers
Summary
Cancer Care and Hematology-Fort Collins is a medical facility located in Fort Collins, Colorado. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence, Breast Cancer and other specialties. Cancer Care and Hematology-Fort Collins is involved with conducting 63 clinical trials across 133 conditions. There are 27 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Robert Hoyer, MD, and Breelyn Wilky, M.D..Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Bradley R. CorrUniversity of Colorado Hospital1 year of reported clinical research
Studies Ovarian Cancer
Studies Cancer
20 reported clinical trials
33 drugs studied
Jose M. PachecoUniversity of Colorado Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
30 drugs studied
Robert Hoyer, MDUCHealth Memorial Hospital Central4 years of reported clinical research
Studies Cancer
Studies Tumors
18 reported clinical trials
33 drugs studied
Breelyn Wilky, M.D.University of Colorado1 year of reported clinical research
Studies Sarcoma
Studies Soft Tissue Sarcoma
17 reported clinical trials
28 drugs studied
Clinical Trials running at Cancer Care and Hematology-Fort Collins
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Bladder Cancer
Urothelial Carcinoma
Small Cell Lung Cancer
Colorectal Cancer
Ovarian Tumors
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy Reduction After Surgery
for Breast Cancer
This trial studies how well paclitaxel, trastuzumab, and pertuzumab work in eliminating further chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery (either in the breast or underarm lymph nodes) after pre-operative chemotherapy and HER2-targeted therapy. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Trastuzumab and pertuzumab are both a form of "targeted therapy" because they work by attaching themselves to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When these drugs attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving paclitaxel, trastuzumab, and pertuzumab may enable fewer chemotherapy drugs to be given without compromising patient outcomes compared to the usual treatment.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Care and Hematology-Fort Collins?
Cancer Care and Hematology-Fort Collins is a medical facility located in Fort Collins, Colorado. This center is recognized for care of Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Recurrence, Breast Cancer and other specialties. Cancer Care and Hematology-Fort Collins is involved with conducting 63 clinical trials across 133 conditions. There are 27 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Robert Hoyer, MD, and Breelyn Wilky, M.D..